Skip to content
Sleep & circadian healthEvidence review3 min read

Severe sleep apnoea linked to about double the risk of major cardiac events and stroke

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Association of obstructive sleep apnoea with the risk of vascular outcomes and all-cause mortality: a meta-analysis. · BMJ open · 2017 · Original paper ↗

Key takeaway

Pooling 16 prospective cohort studies of 24,308 people, severe obstructive sleep apnoea was linked to about double the risk of major adverse cardiac events (RR 2.04, 95% CI 1.56 to 2.66) and stroke (RR 2.15, 95% CI 1.42 to 3.24), while mild apnoea showed no significant link. These are observational studies, so the associations do not prove that apnoea itself causes the events.

Study design

Evidence review

Reading basis

Published abstract

Reading focus

Design & applicability

The research question

Obstructive sleep apnoea (OSA) is common, and it is unclear how much it adds to the later risk of heart disease, stroke and death. The authors pooled prospective studies to see how different levels of OSA severity relate to major adverse cardiac events (MACEs), coronary heart disease, stroke, cardiac death, heart failure and all-cause mortality.

Who and how

Meta-analysis of prospective cohort studies. PubMed, Embase and the Cochrane Library were searched for studies up to May 2016. Studies had to report effect estimates with 95% CIs for MACEs, coronary heart disease (CHD), stroke, cardiac death, all-cause mortality or heart failure, comparing levels of OSA with the lowest level. 16 cohort studies with 24,308 individuals were included; 11 studies enrolled healthy participants and the remaining 5 enrolled people with various diseases.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Severe OSA was linked to higher risk of MACEs (RR 2.04; 95% CI 1.56 to 2.66; P < 0.001), CHD (RR 1.63; 1.18 to 2.26; P = 0.003), stroke (RR 2.15; 1.42 to 3.24; P < 0.001), cardiac death (RR 2.96; 1.45 to 6.01; P = 0.003) and all-cause mortality (RR 1.54; 1.21 to 1.97; P < 0.001).
  2. 2
    Moderate OSA was linked to modestly higher risk of MACEs (RR 1.16; 95% CI 1.01 to 1.33; P = 0.034) and CHD (RR 1.38; 1.04 to 1.83; P = 0.026).
  3. 3
    Mild OSA showed no significant association with any vascular outcome or all-cause mortality (P > 0.05).
  4. 4
    The authors found no evidence that the risk ratio for MACEs differed by factor-specific subgroup, and say the relationship might differ between genders, which needs checking in larger prospective studies.

Limits & uncertainty

  1. 1
    Only observational cohort studies were pooled, so unmeasured factors such as obesity, other illness or treatment could explain part of the links.
  2. 2
    Studies differed in who they enrolled: 11 had healthy participants and 5 had people with various diseases.
  3. 3
    The abstract does not say how OSA severity was measured or how often participants received treatment.
  4. 4
    The suggested gender difference is untested and the authors call for further large prospective studies; this reading is based on the abstract only.

What to take from it

The pooled results suggest that moderate and especially severe sleep apnoea go with a higher chance of heart problems and stroke later, while mild apnoea showed no clear link. This does not show that treating apnoea will lower those risks. If you snore loudly, stop breathing at night or feel sleepy by day, discuss testing with your clinician.

Reading your own data

Some watches and rings estimate breathing disturbances or blood oxygen during sleep, but they cannot diagnose sleep apnoea or give an apnoea severity level. Repeated night-to-night patterns on the same device, shared with a clinician, can prompt a proper sleep study.

How to read this evidence

Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Objective

This study aimed to conduct a meta-analysis to explore and summarise the evidence regarding the association between obstructive sleep apnoea (OSA) and the subsequent risk of vascular outcomes and all-cause mortality.

Methods

Electronic databases PubMed, Embase and the Cochrane Library were searched to identify studies conducted through May 2016. Prospective cohort studies that reported effect estimates with 95% CIs of major adverse cardiac events (MACEs), coronary heart disease (CHD), stroke, cardiac death, all-cause mortality and heart failure for different levels versus the lowest level of OSA were included.

Results

A total of 16 cohort studies reporting data on 24 308 individuals were included. Of these, 11 studies reported healthy participants, and the remaining five studies reported participants with different diseases. Severe OSA was associated with an increased risk of MACEs (relative risk (RR): 2.04; 95% CI 1.56 to 2.66; P<0.001), CHD (RR: 1.63; 95% CI 1.18 to 2.26; P=0.003), stroke (RR: 2.15; 95% CI 1.42 to 3.24; P<0.001), cardiac death (RR: 2.96; 95% CI 1.45 to 6.01; P=0.003) and all-cause mortality (RR: 1.54; 95% CI 1.21 to 1.97; P<0.001). Moderate OSA was also significantly associated with increased risk of MACEs (RR: 1.16; 95% CI 1.01 to 1.33; P=0.034) and CHD (RR: 1.38; 95% CI 1.04 to 1.83; P=0.026). No significant association was found between mild OSA and the risk of vascular outcomes or all-cause mortality (P>0.05). Finally, no evidence of a factor-specific difference in the risk ratio for MACEs among participants with different levels of OSA compared with those with the lowest level of OSA was found.

Conclusions

Severe and moderate OSAs were associated with an increased risk of vascular outcomes and all-cause mortality. This relationship might differ between genders. Therefore, further large-scale prospective studies are needed to verify this difference.

Sources & attribution

Association of obstructive sleep apnoea with the risk of vascular outcomes and all-cause mortality: a meta-analysis.

Xie C, Zhu R, Tian Y, Wang K.

BMJ open · 2017-12-22

DOI: 10.1136/bmjopen-2016-013983 ↗PubMed · 29275335 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Trial meta-analysis

Exercise improved sleep-quality scores in adults 45 and older with sleep disorders

Pooling 23 randomized trials with 1,478 adults aged 45 to 77 who had sleep disorders, exercise improved Pittsburgh Sleep Quality Index scores (SMD 0.62, 95% CI 0.40–0.83), and aerobic exercise showed the largest effect in the network analysis (SMD 1.34, 95% CrI 0.86–1.82). Certainty was low to moderate, the outcomes were questionnaires, and the best weekly dose of about 539 MET-min/week is a model estimate, not a prescription.

Journal of Exercise Science & Fitness

In-depth explainersRead study →
·Cohort study

Sleep regularity tracked mortality more closely than sleep duration in 60,977 UK adults

Among 60,977 UK Biobank adults who wore a wrist accelerometer for a week, the most regular fifth of sleepers had a fully adjusted all-cause mortality HR of 0.70 (95% CI 0.59–0.83) against the least regular fifth, over about 6.3 years and 1859 deaths. Regularity fitted the data better than sleep duration, but the study is observational and rests on one week of sleep data.

Sleep

In-depth explainersRead study →
·Randomised trial

Sleep extension cut daily energy intake by about 270 kcal in adults with overweight

In 80 adults with overweight who usually slept under 6.5 hours, two weeks of sleep-extension counselling added about 1.2 hours of sleep and lowered measured energy intake by 270.4 kcal/d versus control (95% CI −393.4 to −147.4). The trial was short, single-centre and in a narrow group, so it does not show lasting weight loss or any benefit for people who already sleep enough.

JAMA Internal Medicine

In-depth explainersRead study →
·Cohort study

Six hours or less of sleep at 50 and 60 linked to higher dementia risk

In 7959 British civil servants followed for about 25 years, sleeping six hours or less at age 50 (HR 1.22, 95% CI 1.01–1.48) or age 60 (HR 1.37, 1.10–1.72) was linked to a higher dementia rate than sleeping seven hours, and persistent short sleep gave an HR of 1.30 (1.00–1.69). Sleep was mostly self-reported and the study is observational, so early brain disease or other factors may explain part of the link.

Nature Communications

In-depth explainersRead study →
Sleep & circadian health →